FDVAX Performance — Fidelity Advisor Diversified International Fund, Class A
Data updated: 2026-09-23
FDVAX returned +11.79% year to date and +22.60% over one year to Jul 2026. Over one year the fund trailed its International Multi-Cap Blend category average: $100 grew to $123, against $125 for the category. Volatility over the past 12 months was 14.82% a year. In the 12 months to Jul 2026 the fund took in a net $168.8M, and assets reached $1.83B.
FDVAX Growth of $100
What $100 invested in Fidelity Advisor Diversified International Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Multi-Cap Blend category average over the same months.
| Period | FDVAX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $123 | $125 |
| 3 years (Aug 2023 – Jul 2026) | $50 | $159 |
| 5 years (Aug 2021 – Jul 2026) | $11 | $155 |
| Since data start (Aug 2019 – Jul 2026) | $4 | $204 |
FDVAX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.79% |
| 1 year | +22.60% |
3- and 5-year figures withheld: returns differ from sibling classes.
FDVAX Annual Returns
Calendar-year total returns of Fidelity Advisor Diversified International Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.79% |
| 2025 | +13.18% |
| 2024 | −47.83% |
| 2023 | −42.46% |
| 2022 | −62.61% |
| 2021 | −44.66% |
| 2020 | −41.40% |
| 2019 (Aug–Dec) | −17.22% |
FDVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.3% | +3.7% | −9.1% | +8.2% | +3.4% | +2.6% | −1.9% | — | — | — | — | — |
| 2025 | −0.9% | −4.6% | −1.2% | +4.3% | +5.1% | +3.4% | −2.4% | +1.9% | +3.2% | +1.9% | −0.5% | +2.9% |
| 2024 | −5.4% | −1.7% | −2.7% | −9.4% | −1.2% | −6.3% | −4.0% | −2.6% | −5.4% | −10.1% | −5.2% | −8.9% |
| 2023 | +2.4% | −8.6% | −2.7% | −4.1% | −7.2% | −1.8% | −4.1% | −9.4% | −9.9% | −8.8% | +2.3% | −1.1% |
| 2022 | −13.6% | −9.9% | −5.5% | −13.5% | −5.8% | −15.0% | +0.5% | −11.4% | −14.2% | −0.5% | +5.8% | −8.9% |
| 2021 | −7.4% | −4.7% | −5.1% | −2.5% | −2.5% | −6.0% | −4.0% | −2.2% | −9.5% | −2.8% | −7.7% | −3.0% |
| 2020 | −6.9% | −11.8% | −18.1% | +2.7% | 0.0% | −0.5% | −1.1% | −1.4% | −6.5% | −9.2% | +3.9% | −0.9% |
| 2019 | — | — | — | — | — | — | — | −6.5% | −4.0% | −2.3% | −3.9% | −1.9% |
FDVAX Risk
Risk measures from monthly returns over Aug 2025 – Jul 2026.
- 1-year volatility (annualised): 14.82%
- Best month: +8.20% (Apr 2026)
- Worst month: −9.14% (Mar 2026)
FDVAX Fund Flows
Monthly money in and out of Fidelity Advisor Diversified International Fund, from SEC Form N-PORT.
- 12-month net flow: $168.8M
- 12-month gross sales (incl. reinvestments): $497.9M
- Sales ÷ redemptions: 1.51×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $21.3M | $23.3M | −$2.0M |
| Jun 2026 | $32.1M | $22.9M | $9.1M |
| May 2026 | $52.5M | $23.0M | $29.5M |
| Apr 2026 | $17.7M | $21.3M | −$3.7M |
| Mar 2026 | $20.4M | $27.5M | −$7.1M |
| Feb 2026 | $21.2M | $60.7M | −$39.5M |
| Jan 2026 | $26.6M | $28.5M | −$1.9M |
| Dec 2025 | $233.1M | $38.5M | $194.5M |
| Nov 2025 | $13.6M | $20.9M | −$7.3M |
| Oct 2025 | $18.9M | $22.2M | −$3.3M |
| Sep 2025 | $22.6M | $18.5M | $4.1M |
| Aug 2025 | $17.9M | $21.7M | −$3.8M |
FDVAX Assets Under Management
Net assets of Fidelity Advisor Diversified International Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.83B |
| 2026-04-30 | $1.72B |
| 2026-01-31 | $1.74B |
| 2025-10-31 | $1.63B |
| 2025-07-31 | $1.52B |
| 2025-04-30 | $1.44B |
| 2025-01-31 | $1.40B |
| 2024-10-31 | $1.40B |
| 2024-07-31 | $1.44B |
| 2024-04-30 | $1.38B |
| 2024-01-31 | $1.46B |
| 2023-10-31 | $1.31B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.